NCT07350798

Brief Summary

  • Objective assessment of clinical symptoms, mobility and quality of life changes resulting from stroke and determination of changes resulting from therapies.
  • Assessment of the rehabilitation effectiveness of traditional treadmill training.
  • Assessment of the rehabilitation effectiveness of gait training performed on a treadmill with a robot-assisted soft-exoskeleton.
  • Assessment of the rehabilitation effectiveness of treadmill training supplemented with virtual and augmented reality.
  • Determination of the joint application possibilities of robot-assisted and virtual and augmented reality treadmill training in order to further increase the effectiveness.
  • Comparison of the effectiveness of different treadmill trainings.
  • Mapping of changes in gait patterns due to therapies using 3D motion analysis.
  • Mapping of changes in postural stability due to therapies using posturography.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
28mo left

Started Aug 2025

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress26%
Aug 2025Aug 2028

Study Start

First participant enrolled

August 1, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 15, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 20, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2028

Last Updated

January 20, 2026

Status Verified

January 1, 2026

Enrollment Period

1.4 years

First QC Date

December 15, 2025

Last Update Submit

January 9, 2026

Conditions

Keywords

strokeroboticvirtual realityaugmented realityrehabilitationtreadmill training

Outcome Measures

Primary Outcomes (1)

  • Modified Rankin Scale (mRS)

    The modified Rankin Scale (mRS) indicates the degree of independence in daily activities and the severity of disability. The method for assessing mRs is a guided interview. . The scoring is divided as follows: 0-No symptoms; 1-No significant disability. Able to carry out activities of daily living despite some symptoms; 2-Mild disability. Able to look after himself without assistance but not able to carry out all previous activities; 3-Moderate disability. Needs some assistance with activities of daily living but can walk without assistance; 4-Moderately severe disability. Unassisted, unable to meet his/her own physical needs, unable to walk without assistance; 5-Severe disability. Bedridden, incontinent, requires constant nursing care; 6-Dead

    3 weeks

Secondary Outcomes (10)

  • 36-Item Short Form Survey (SF-36)

    3 weeks

  • Stroke Impact Scale-16 (SIS-16)

    3 weeks

  • Berg Balance Scale (BBS)

    3 weeks

  • Tinetti test

    3 weeks

  • 6 minute walking test (6MWT)

    3 weeks

  • +5 more secondary outcomes

Study Arms (4)

TT

EXPERIMENTAL

Receiving high intensity treadmill training

Other: Treadmill Training

R-TT

EXPERIMENTAL

Receiving high intensity treadmill training with ReStore robotic device.

Other: Robot Assisted Treadmill Training

VR&AR-TT

EXPERIMENTAL

Receiving treadmill training with C-Mill, a special treadmill that provides virtual and augmented reality.

Other: Treadmill Training with Virtual and Augmented Reality

C-TT

EXPERIMENTAL

Receiving treadmill training with the combination of the ReStore and C-Mill system.

Other: Combined Treadmill Training

Interventions

The TT group performs high-intensity treadmill training on a conventional treadmill. 5 times/week for 3 weeks, 30 minutes each.

TT

The TT group performs high-intensity treadmill training on a conventional treadmill. Before the training begins, the ReStore Soft exoskeleton, which is a special gait assist device, is fitted. The device uses motion sensors to process the movements of the lower limb on the healthy side and uses a motor attached to the waist to map them using bowden cables while walking on the affected paretic side in real time. During therapy, the amount of assistance provided by the exoskeleton can be continuously adjusted to the patient's needs from an external controller, so that therapy can be performed in a specialized manner for the individual. 5 times/week for 3 weeks, 30 minutes each.

R-TT

The VR\&AR-TT group performs treadmill training on a special treadmill, the C-Mill VR+ device, for which the virtual and augmented reality movement programs are provided by the CueFors 2.5 software, which is the original control software for the C-Mill. The C-Mill VR+ system is a 3 m long and 1 m wide treadmill with a force platform underneath. A 65" fixed-position monitor in front of the treadmill provides the virtual reality environment, and a projector placed next to the treadmill allows various tasks to be projected onto the treadmill belt, providing immediate real-time feedback to the patient and therapist via the force platform. 5 times/week for 3 weeks, 30 minutes each.

VR&AR-TT

Patients in the C-TT group use the ReStore Soft exoskeleton and the C-Mill VR+ system together. 5 times/week for 3 weeks, 30 minutes each.

C-TT

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • has had a first ischemic stroke diagnosed by a neurologist based on CT or MRI;
  • neurological examination shows mobility and postural limitations;
  • mRS score of 2 or higher;

You may not qualify if:

  • multiple strokes in the medical history;
  • systolic blood pressure less than 120 or greater than 160 mmHg;
  • orthostatic hypotension;
  • carotid artery stenosis;
  • severe heart disease;
  • hemophilia;
  • traumatic brain injury;
  • seizure disorder; untreated diabetes;
  • abnormal electroencephalography;
  • Mini Mental Test score \< 22;
  • abnormal blood panel;
  • use of sedatives; irregular medication;
  • severe aphasia (Western Aphasia Battery ≤ 25);
  • severe vision or hearing impairment;
  • severe sensory dysfunction;
  • +10 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Somogy County Kaposi Mór Teaching Hospital

Kaposvár, Somogy County, 7400, Hungary

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • József Dr. habil. Tollár

    Somogy County Kaposi Mór Teaching Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

József Dr. habil. Tollár

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Department

Study Record Dates

First Submitted

December 15, 2025

First Posted

January 20, 2026

Study Start

August 1, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

August 1, 2028

Last Updated

January 20, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations